Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8089
Corporate User License Price USD 375
Corporate User License Price INR 24266
Site License Price USD 250
Site License Price INR 16178
Request a Quote

Report Title

La Jolla Pharmaceutical Company (LJPC)-Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

La Jolla Pharmaceutical Company (LJPC)-Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

La Jolla Pharmaceutical Company (LJPC)-Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

La Jolla Pharmaceutical Company (LJPC)-Financial and Strategic SWOT Analysis Review



Executive Summary

La Jolla Pharmaceutical Company (LJPC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

La Jolla Pharmaceutical Company (La Jolla) is a biopharmaceutical company, which discovers, develops and markets pharmaceutical products for life threatening diseases. The company's product pipeline includes LJPC-501, a formulation of angiotensin II is being developed for the treatment of catecholamine-resistant hypotension; LJPC-401, formulation of synthetic human hepcidin for the treatment of iron overload such as hereditary hemochromatosis, myelodysplastic syndrome and sickle cell disease; and LJPC-30S, a gentamicin derivative program is being developed for the treatment of serious bacterial infections and rare genetic disorders including cystic fibrosis and Duchenne muscular dystrophy. La Jolla is headquartered in San Diego, California, the US.

La Jolla Pharmaceutical Company Key Recent Developments

Jul 27,2017: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress

Apr 27,2017: La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress

Feb 23,2017: La Jolla Pharmaceutical Company Announces Fourth Quarter and Full Year 2016 Financial Results and Corporate Progress

Nov 03,2016: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2016 and Recent Corporate Progress

Aug 08,2016: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

La Jolla Pharmaceutical Company-Key Facts 6

La Jolla Pharmaceutical Company-Key Employees 7

La Jolla Pharmaceutical Company-Key Employee Biographies 8

La Jolla Pharmaceutical Company-Major Products and Services 9

La Jolla Pharmaceutical Company-History 10

La Jolla Pharmaceutical Company-Company Statement 11

La Jolla Pharmaceutical Company-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

La Jolla Pharmaceutical Company-Business Description 14

La Jolla Pharmaceutical Company-SWOT Analysis 15

SWOT Analysis-Overview 15

La Jolla Pharmaceutical Company-Strengths 15

La Jolla Pharmaceutical Company-Weaknesses 16

La Jolla Pharmaceutical Company-Opportunities 17

La Jolla Pharmaceutical Company-Threats 18

La Jolla Pharmaceutical Company-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27

La Jolla Pharmaceutical Company, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

Jul 27, 2017: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress 29

Apr 27, 2017: La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress 30

Feb 23, 2017: La Jolla Pharmaceutical Company Announces Fourth Quarter and Full Year 2016 Financial Results and Corporate Progress 31

Nov 03, 2016: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2016 and Recent Corporate Progress 32

Aug 08, 2016: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2016 33

May 06, 2016: La Jolla Pharmaceutical Company Announces First Quarter 2016 Financial Results and Recent Corporate Progress 34

Feb 25, 2016: La Jolla Pharmaceutical Company Announces Fourth Quarter and Full Year 2015 Financial Results and Highlights Corporate Progress 35

Section 6-Appendix 36

Methodology 36

Ratio Definitions 36

About GlobalData 40

Contact Us 40

Disclaimer 40

To know more information on Purchase by Section, please send a mail to query@kenresearch.com

List of Figures

La Jolla Pharmaceutical Company, Performance Chart (2012-2016) 23

La Jolla Pharmaceutical Company, Ratio Charts 25

La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 27

List of Tables

La Jolla Pharmaceutical Company, Key Facts 6

La Jolla Pharmaceutical Company, Key Employees 7

La Jolla Pharmaceutical Company, Key Employee Biographies 8

La Jolla Pharmaceutical Company, Major Products and Services 9

La Jolla Pharmaceutical Company, History 10

La Jolla Pharmaceutical Company, Subsidiaries 13

La Jolla Pharmaceutical Company, Key Competitors 19

La Jolla Pharmaceutical Company, Ratios based on current share price 20

La Jolla Pharmaceutical Company, Annual Ratios 21

La Jolla Pharmaceutical Company, Annual Ratios (Cont...1) 22

La Jolla Pharmaceutical Company, Interim Ratios 24

La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26

La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27

La Jolla Pharmaceutical Company, Recent Deals Summary 28

Currency Codes 36

Capital Market Ratios 36

Equity Ratios 37

Profitability Ratios 37

Cost Ratios 38

Liquidity Ratios 38

Leverage Ratios 39

Efficiency Ratios 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

La Jolla Pharmaceutical Company, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand